Silver Book Fact

Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained life-years. Additionally, it would save up to $18 million.

Phiillips K, Shlipak M, Coxon P, Heidenreich P, et al. Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. JAMA. 2000; 284(21): 2748-54. http://jama.ama-assn.org/cgi/content/abstract/284/21/2748

Reference

Title
Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction
Publication
JAMA
Publication Date
2000
Authors
Phiillips K, Shlipak M, Coxon P, Heidenreich P, et al.
Volume & Issue
Volume 284, Issue 21
Pages
2748-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Death rates from heart disease have decreased from 586.6 deaths per 100,000 persons in 1950, to 240.8 deaths per 100,000 persons in 2002.  
  • From 1999-2000, average blood pressures for Americans age 40 and older would have been 10-13% higher without antihypertensive drug therapy.  
  • Death rates from heart disease and stroke are falling in-part because of new drug treatments. According to the National Heart, Lung and Blood Institute, if death rates were the same…  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.